Lucid Engage vs Resound Vivia 9 60S microRIE

The Lucid Engage is a mid-priced OTC hearing aid that earned an A grade with a SoundScore of 4.2/5 in our lab testing, ranking #14 among 65 OTC devices tested. Priced at $850, this behind-the-ear rechargeable device has received our Expert's Choice Award in both 2023 and 2024. In our testing, the Engage demonstrated strong speech clarity in quiet environments, scoring 4.3/5—a full 1.46 points above the OTC category average. Speech understanding in noisy settings scored 2.4/5, which is above the category average by 0.94 points but remains mixed in absolute terms. Own-voice comfort was solid at 3.6/5, exceeding the category average by over a point, which should help with natural-sounding self-perception during conversations. The device's main weakness is feedback handling, scoring 2.6/5—nearly 2 points below the category average of 4.54/5. Users may experience more whistling or feedback artifacts compared to other OTC options. Music streaming quality was mixed at 2.4/5, slightly above average but not a standout feature. The Lucid Engage is well-suited for consumers prioritizing speech clarity in everyday quiet-to-moderate listening situations who can accept trade-offs in feedback stability. Buyers in this price range may also consider alternatives like the Sony CRE-E10 or Lexie B2 Plus, which scored higher in our testing. The Engage supports both iPhone and Android streaming and offers rechargeable convenience.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.